or Try an Advanced Search...

    Solid Tumors Stocks List

    Symbol Grade Name % Change
    XOMA C XOMA Corporation 0.43
    ACHL C Achilles Therapeutics plc -0.93
    EBS C Emergent Biosolutions, Inc. 0.85
    REPL B Replimune Group, Inc. 35.11
    CNTA B Centessa Pharmaceuticals plc -6.32
    LGND B Ligand Pharmaceuticals Incorporated 2.27
    ARGX A argenx SE 1.54
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Other Shell Companies
    Related Stock Lists: Cancer Medicine Immunotherapy Biotechnology Cancer Immunotherapy Cancer Treatment Chronic Lymphocytic Leukemia Clinical Medicine Drugs Immune System Lymphocytic Leukemia Multiple Myeloma Myelodysplastic Syndrome Non Small Cell Lung Cancer Orphan Drug Pharmaceutical Rheumatoid Arthritis Thrombocytopenia Acne Acute Myeloid Leukemia

    Related ETFs - A few ETFs which own one or more of the above listed Solid Tumors stocks.

    Symbol Grade Name Weight
    CNCR F Loncar Cancer Immunotherapy ETF 2.11
    CANC F Tema Oncology ETF 1.52
    BBC F Virtus LifeSci Biotech Clinical Trials ETF 1.25
    LRNZ A TrueMark Technology, AI & Deep Learning ETF 0.8
    XBI D SPDR S&P Biotech ETF 0.39
    View all Solid Tumors ETFs...
    Compare ETFs
    Compare BBC to LRNZ Compare CANC to BBC Compare CNCR to BBC

        Solid Tumors Stocks Recent News

        Date Stock Title
        Nov 22 REPL S&P 500 Moves Higher; Intuit Shares Fall Following Q1 Results
        Nov 22 REPL Replimune Stock Rallies on BLA Filing for Melanoma Combo Drug
        Nov 22 REPL Replimune climbs after updates on lead drug
        Nov 22 REPL Replimune's stock surges 19% after-hours on FDA BLA submission
        Nov 22 ARGX Halozyme drops Evotec buyout bid; Patient dies in Neurogene trial
        Nov 21 REPL Replimune Receives Breakthrough Therapy Designation for RP1 and Submits RP1 Biologics License Application to the FDA under the Accelerated Approval Pathway
        Nov 20 ARGX argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies
        Nov 19 ACHL US Penny Stocks To Watch In November 2024
        Nov 19 ACHL Achilles Therapeutics Receives Approval to Transfer to Nasdaq Capital Market
        Nov 18 ARGX Is argenx SE (ARGX) the Best Immunotherapy Stock to Buy Now?
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Other Shell Companies
        Related Stock Lists: Cancer Clinical Medicine Medicine Advanced Solid Tumors Oncology Acute Myeloid Leukemia Biopharmaceutical Cancer Immunotherapy Cancer Treatment Immune System Tumors Of The Hematopoietic And Lymphoid Tissues Antineoplastic Drugs Biotechnology Chemotherapy Drugs Hematologic Malignancies Hematological Malignancies Immunology Immunotherapy Lymphoma
        Solid Tumors

        Solid tumors are masses of abnormal cells that form when cells in the body divide and grow uncontrollably. They are usually found in the organs, but can also form in the tissues of the body. Solid tumors can be benign (non-cancerous) or malignant (cancerous).

        Browse All Tags